Adelaide-based artificial intelligence software vendor Complexica has secured a software deployment contract with pharmaceutical company Pfizer Australia.
The deal will see Pfizer roll out Complexica’s What-if Simulator, powered by artificial intelligence engine, Larry, the Digital Analyst.
Complexica will provide the pharma company with the ability to test a variety of scenarios based on internal and external datasets across the areas of marketing and business operations. The software will analyse Pfizer’s variables and data across several metrics.
“After evaluating a number of software companies in the marketplace that possess advanced prediction and optimisation capabilities, we have ultimately selected Complexica as our vendor of choice.” Pfizer Australian brand manager Andrew Endicott said.
“We have found that answering complex 'what-if' questions is a challenging and time-consuming endeavour, and we believe that Complexica’s What-if Simulator can provide Pfizer Australia with a platform for scenario analysis that will improve our decision-making in the future. We look forward to working with Complexica to address some of the analytical and “what-if” challenges facing our business and operating environment.”
Complexica chief scientist Zbigniew Michalewicz said he was delighted Pfizer had selected the AI company as a software partner in this area.
“We look forward to applying our software, science, and know-how to help Pfizer Australia answer complex questions and optimise some of their decisions and strategies going forward,” he said.